An initial oral combination of drugs is being recommended in pulmonary arterial hypertension (PAH), but the effects of this approach on risk reduction and pulmonary vascular resistance (PVR) are not known
Pulmonary arterial hypertension (PAH) is a complex, progressive disease with several pathobiological...
Combination therapy is now regarded as the standard of care in pulmonary arterial hypertension (PAH)...
International audienceTreatment for pulmonary arterial hypertension (PAH) has been underpinned by si...
An initial oral combination of drugs is being recommended in pulmonary arterial hypertension (PAH), ...
Rationale: An initial oral combination of drugs is being recommended in pulmonary arterial hypertens...
Pulmonary arterial hypertension (PAH) is a disorder of the small pulmonary arteries characterized by...
Pulmonary arterial hypertension (PAH) is a progressively fatal disease, and the goal in treatment is...
Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability o...
There is a strong clinical rationale for combination therapy in pulmonary arterial hypertension (PAH...
Multiple medical therapies have been developed for the treatment of pulmonary arterial hypertension ...
Rationale Demographic characteristics of pulmonary arterial hypertension (PAH) patients have changed...
Pulmonary arterial hypertension (PAH) is defined as a mean pulmonary artery pressure ≥ 25 mmHg at re...
Pulmonary arterial hypertension (PAH) is characterized by progressive increases in mean pulmonary ar...
Pulmonary arterial hypertension (PAH) is a complex, progressive disease with several pathobiological...
Combination therapy is now regarded as the standard of care in pulmonary arterial hypertension (PAH)...
International audienceTreatment for pulmonary arterial hypertension (PAH) has been underpinned by si...
An initial oral combination of drugs is being recommended in pulmonary arterial hypertension (PAH), ...
Rationale: An initial oral combination of drugs is being recommended in pulmonary arterial hypertens...
Pulmonary arterial hypertension (PAH) is a disorder of the small pulmonary arteries characterized by...
Pulmonary arterial hypertension (PAH) is a progressively fatal disease, and the goal in treatment is...
Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability o...
There is a strong clinical rationale for combination therapy in pulmonary arterial hypertension (PAH...
Multiple medical therapies have been developed for the treatment of pulmonary arterial hypertension ...
Rationale Demographic characteristics of pulmonary arterial hypertension (PAH) patients have changed...
Pulmonary arterial hypertension (PAH) is defined as a mean pulmonary artery pressure ≥ 25 mmHg at re...
Pulmonary arterial hypertension (PAH) is characterized by progressive increases in mean pulmonary ar...
Pulmonary arterial hypertension (PAH) is a complex, progressive disease with several pathobiological...
Combination therapy is now regarded as the standard of care in pulmonary arterial hypertension (PAH)...
International audienceTreatment for pulmonary arterial hypertension (PAH) has been underpinned by si...